EMA Authorised: Latuda (lurasidone) — Aziende Chimiche Riunite Angelini Francesco S.p.A.

View source ↗

Summary

The European Medicines Agency authorised Latuda (lurasidone) for schizophrenia, with Aziende Chimiche Riunite Angelini Francesco S.p.A. as the marketing authori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Latuda (lurasidone)

Snippet

Status: Authorised. Therapeutic area: Schizophrenia. MAH: Aziende Chimiche Riunite Angelini Francesco S.p.A.. Decision date: 12/01/2026